Stämm Vegh SA develops solutions for biomanufacturing, bioengineering and bio‑AI to support biologics and cell therapy production and cell line development. Its offerings include a plug‑and‑play continuous bioreactor (the Bioprocessor) with a bubble‑free bioreactor, automated cell‑line engineering and clone‑selection platforms, and MoNA™ — a transomics platform for multi‑omic analysis and in‑silico cell simulation.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Plug & play continuous biomanufacturing with automated, closed-loop production, parallelized homogeneous run conditions, cloud control, and a high-throughput bioprocessor for biologics and cell therapies.
Bioengineering
End-to-end solutions for cell line development, including automated cell engineering, clone outgrowth, clone selection and screening for biologics production.
Bio AI
Multi-omic data analysis and cell-predictive pipelines using AI generative models, including in-silico modelling, assay support, and environmental parameter recommendations.
Comparisons
Stämm Vegh SA in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Stämm Vegh SA by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Stämm Vegh SA has claimed this profile, we'll publish editorial articles and case studies here together.